Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessment of Factors Which Predict Improvement in Children With PDD After a Year of Integrative Therapy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2007 by BeerYaakov Mental Health Center.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
BeerYaakov Mental Health Center
ClinicalTrials.gov Identifier:
NCT00531830
First received: September 18, 2007
Last updated: September 25, 2007
Last verified: September 2007
  Purpose

The aim of the current research is to assess the efficiency of the Integrative Therapy among children with PDD after a year of treatment in kindergartens in Ashdod, Israel.

An additional aim is to pinpoint specific changes in communication quality and functioning in different areas and recognize the prognostic factors, such as social interaction, affect and level of play. This analysis will contribute to developing more efficient treatment program, adapted to the needs of the treated children.


Condition
Pervasive Developmental Disorder

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Retrospective
Official Title: Assessment of Factors Which Predict Improvement in Children With PDD After a Year of Integrative Therapy

Further study details as provided by BeerYaakov Mental Health Center:

Estimated Enrollment: 60
Study Start Date: September 2007
Estimated Study Completion Date: September 2011
Groups/Cohorts
Treatment Comparison: 1
Preschool children with PDD
Control: 2
Preschool children without PDD

Detailed Description:

Integrative Therapy among children with PDD after a year of treatment in kindergartens in Ashdod, Israel.

An additional aim is to pinpoint specific changes in communication quality and functioning in different areas and recognize the prognostic factors, such as social interaction, affect and level of play. This analysis will contribute to developing more efficient treatment program, adapted to the needs of the treated children.

  Eligibility

Ages Eligible for Study:   2 Years to 6 Years   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Children with PDD
  • Children aged from 2 years to 6 years

Exclusion Criteria:

  • Children with severe retardation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00531830

Sponsors and Collaborators
BeerYaakov Mental Health Center
Investigators
Principal Investigator: Irit Orian, M.D. Mental health unit for preschoolers, Ashdod, Israel
Study Director: Beatriz Priel, Prof. Ben Gurion University, Beer-Sheva
Study Chair: Alexander Rejba, M.A. Ben-Gurion University, Beer-Sheva
  More Information

ClinicalTrials.gov Identifier: NCT00531830     History of Changes
Other Study ID Numbers: Children with PDD -31CTIL 
Study First Received: September 18, 2007
Last Updated: September 25, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by BeerYaakov Mental Health Center:
children with PDD

Additional relevant MeSH terms:
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Autistic Disorder
Developmental Disabilities
Neurodevelopmental Disorders
Mental Disorders

ClinicalTrials.gov processed this record on December 08, 2016